AR116635A1 - Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen - Google Patents

Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen

Info

Publication number
AR116635A1
AR116635A1 ARP190102897A ARP190102897A AR116635A1 AR 116635 A1 AR116635 A1 AR 116635A1 AR P190102897 A ARP190102897 A AR P190102897A AR P190102897 A ARP190102897 A AR P190102897A AR 116635 A1 AR116635 A1 AR 116635A1
Authority
AR
Argentina
Prior art keywords
bromophenil
piperazinil
etoxy
synthesis
derivatives
Prior art date
Application number
ARP190102897A
Other languages
English (en)
Inventor
Bruno Schiavi
Christophe Hardouin
Pascall Giguere
Martial Bertrand
Louis-Philippe Beauregard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR116635A1 publication Critical patent/AR116635A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Abstract

Reivindicación 1: Un proceso para preparar un compuesto de fórmula (1), en donde: R¹ y R² independientemente uno de otro representan un átomo de halógeno, un grupo alquilo C₁₋₆ lineal o ramificado, un grupo alcoxi C₁₋₆ lineal o ramificado, un grupo alcoxi C₁₋₆alcoxi C₁₋₆ lineal o ramificado, un grupo hidroxilo o un grupo ciano; R³ representa un grupo alquilo C₁₋₆ lineal o ramificado, que comprende la etapa de hacer reaccionar un compuesto de fórmula (2), en donde R¹ y R² son como se han definido anteriormente, con un compuesto de fórmula (3), en donde R³ es como se ha definido anteriormente, y X⁻ representa un contraión aniónico monovalente, en un disolvente, a alta temperatura en presencia de una base.
ARP190102897A 2018-10-15 2019-10-11 Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen AR116635A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18306354 2018-10-15

Publications (1)

Publication Number Publication Date
AR116635A1 true AR116635A1 (es) 2021-05-26

Family

ID=63965576

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190102897A AR116635A1 (es) 2018-10-15 2019-10-11 Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen

Country Status (15)

Country Link
US (1) US11512062B2 (es)
EP (1) EP3867233A1 (es)
JP (1) JP7448532B2 (es)
KR (1) KR20210076094A (es)
CN (1) CN112930340A (es)
AR (1) AR116635A1 (es)
AU (1) AU2019362310A1 (es)
BR (1) BR112021006467A2 (es)
CA (1) CA3115608A1 (es)
EA (1) EA202190989A1 (es)
IL (1) IL282094A (es)
MA (1) MA53897A (es)
MX (1) MX2021004288A (es)
TW (1) TW202033506A (es)
WO (1) WO2020078875A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022290855A1 (en) 2021-06-11 2023-12-07 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-body drug conjugates
CA3222269A1 (en) 2021-06-11 2022-12-15 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-cancer agents

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401824A (en) * 1982-03-08 1983-08-30 The Upjohn Company Benzopyran compounds, derivatives of prostaglandins
US6867203B2 (en) * 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
GB0500029D0 (en) 2005-01-04 2005-02-09 Univ Belfast Basic ionic liquids
US7759337B2 (en) 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
WO2007047146A2 (en) * 2005-10-11 2007-04-26 Intermune, Inc. Inhibitors of viral replication
EP2445891A4 (en) 2009-06-26 2012-11-14 Glaxo Group Ltd 5-CHAIN HETEROARYL DERIVATIVES AS SPHINOSINE-1-PHOSPHATE RECEPTOR AGONISTS
EP2500345B1 (en) 2009-11-11 2015-01-28 Sumitomo Dainippon Pharma Co., Ltd. 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
JP6235470B2 (ja) 2011-06-17 2017-11-22 フルイディック，インク．Ｆｌｕｉｄｉｃ，Ｉｎｃ． ジアルキルカーボネートの四級化を利用するヘテロイオン化合物の合成
TWI464242B (zh) * 2012-10-26 2014-12-11 Ind Tech Res Inst 負介電異方性液晶化合物、液晶顯示器、與光電裝置
KR102006994B1 (ko) * 2013-03-28 2019-08-02 주식회사 삼양사 신규 페난트렌 화합물, 이의 제조방법 및 이를 이용한 유기전자소자
WO2015024203A1 (en) 2013-08-20 2015-02-26 Leo Pharma A/S Novel neurokinin 1 receptor antagonist compounds ii
FR3015483B1 (fr) 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CR20160493A (es) 2014-04-25 2016-12-16 Pfizer Compuestos heteroaromáticos y su uso como ligandos de dopamina d1
SG11201609981RA (en) 2014-06-04 2016-12-29 Thomas Helledays Stiftelse För Medicinsk Forskning Mth1 inhibitors for treatment of inflammatory and autoimmune conditions
FR3037959B1 (fr) 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037956B1 (fr) 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3046792B1 (fr) 2016-01-19 2018-02-02 Les Laboratoires Servier Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US10106553B2 (en) 2016-04-11 2018-10-23 Janssen Pharmaceutica Nv Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
KR101891263B1 (ko) * 2016-07-20 2018-08-23 주식회사 엘지화학 신규한 헤테로고리 화합물 및 이를 포함하는 유기발광 소자
US10722466B2 (en) * 2016-10-28 2020-07-28 Les Laboratoires Servier Liposomal formulation for use in the treatment of cancer
CN107573360B (zh) 2017-10-27 2019-08-09 都创(上海)医药科技有限公司 一种多靶点小分子化合物s63845的制备方法

Also Published As

Publication number Publication date
US11512062B2 (en) 2022-11-29
KR20210076094A (ko) 2021-06-23
MX2021004288A (es) 2021-05-31
WO2020078875A1 (en) 2020-04-23
US20210380549A1 (en) 2021-12-09
TW202033506A (zh) 2020-09-16
JP2022512694A (ja) 2022-02-07
MA53897A (fr) 2022-01-19
BR112021006467A2 (pt) 2021-07-13
JP7448532B2 (ja) 2024-03-12
CA3115608A1 (en) 2020-04-23
EA202190989A1 (ru) 2021-07-05
AU2019362310A1 (en) 2021-05-13
CN112930340A (zh) 2021-06-08
IL282094A (en) 2021-05-31
EP3867233A1 (en) 2021-08-25

Similar Documents

Publication Publication Date Title
AR114631A1 (es) Métodos e intermedios para preparar compuestos de piridina
AR091159A1 (es) Derivados de pirrolo[2,3-b]piridina y sintesis de los mismos
AR090760A1 (es) Compuestos de benzotiazol y su uso contra el virus de hiv
AR116635A1 (es) Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen
AR098906A1 (es) Derivados de tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen
AR105104A1 (es) Derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
CY1123154T1 (el) Παραγοντας ενισχυσης της επιδρασης αποκαταστασης μετα απο νευρικη βλαβη που περιλαμβανει ενα παραγωγο αλκυλαιθερα ή ενα αλας αυτου
CY1111528T1 (el) 1-αζα-δικυκλο [3.3.1] εννεανια
AR088829A1 (es) DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3
BR112015022058A2 (pt) 7-azabiciclos substituídos e o uso destes como moduladores do receptor de orexina
AR068538A1 (es) Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido
AR109735A1 (es) Método para la síntesis de derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno e isómero óptico del mismo
AR107549A1 (es) Un proceso para preparar compuesto de pirrolo[3,2-d]pirimidina y su intermediario
AR098818A1 (es) Derivados de oxindol, preparación de los mismos y uso terapéutico de los mismos
AR113842A1 (es) Derivados de tiazol microbiocidas
AR088816A1 (es) Proceso para preparar derivados de 1-acil-4-fenilsulfonilprolinamida y compuestos intermediarios
BR112021026899A2 (pt) Compostos heterocíclicos
AR101798A1 (es) Quinolinas herbicidas
CL2022002255A1 (es) Compuestos heterocíclicos de heteroarilo y usos de los mismos
AR122781A1 (es) Procesos para elaborar compuestos serd tricíclicos que tienen un resto sustituido de fenilo o piridinilo
ES2559854T3 (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica
CY1107034T1 (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ Ν-ΜΟΝΟΫΠΟΚΑΤΕΣΤΗΜΕΝΩΝ β-ΑΜΙΝΟ ΑΛΚΟΟΛΩΝ
AR091499A1 (es) Derivados de pirimidinonas, su preparacion y su aplicacion en terapeutica
BR0212982A (pt) Processo para preparar um composto, e, composto
GB1029228A (en) A method of preparing new quaternary ammonium salts with disinfectant activity